While their data did not reach statistical significance for OS, median progression-free survival (mPFS) was significantly longer in the PET-staged group (11.3 vs. 9.2 months).
← all excerpts
Contemporary real-world radiotherapy outcomes of unresected locally advanced non-small cell lung cancer.
1
—
—